Movement Alert｜JOINN Rises 5.95% in Regular Trading, Life Sciences Sector Broadly Strengthens Amid Primate Supply Tightness Confirmed

Market Focus07-31 10:02

On July 31, JOINN rose 5.95% in regular trading, trading at HKD 23.1/share, with turnover of HKD 49.71 million. The rally was driven by a broad-based rebound across the life sciences tools and services sector, with peers INSILICO up 7.42%, XTALPI up 2.79%, GENSCRIPT BIO up 2.79%, WUXI APPTEC up 2.03%, and WUXI BIO up 1.9%.

On the news front, the company recently confirmed on its investor interaction platform that domestic innovative drug financing and BD licensing transactions continue to recover, driving industry demand growth. Combined with low supply elasticity, non-human primate experimental animals are in a tight supply-demand state, with prices rising from prior levels. The stock had pulled back over 15% cumulatively in the two preceding trading sessions, releasing short-term oversold rebound momentum.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1124527798?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-31 10:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1124527798","market":"us","top_or_hot":-1,"title":"Movement Alert｜JOINN Rises 5.95% in Regular Trading, Life Sciences Sector Broadly Strengthens Amid Primate Supply Tightness Confirmed","media":"Market Focus","content":"<p><p>On July 31, JOINN rose 5.95% in regular trading, trading at HKD 23.1/share, with turnover of HKD 49.71 million. The rally was driven by a broad-based rebound across the life sciences tools and services sector, with peers INSILICO up 7.42%, XTALPI up 2.79%, GENSCRIPT BIO up 2.79%, WUXI APPTEC up 2.03%, and WUXI BIO up 1.9%.</p><p>On the news front, the company recently confirmed on its investor interaction platform that domestic innovative drug financing and BD licensing transactions continue to recover, driving industry demand growth. Combined with low supply elasticity, non-human primate experimental animals are in a tight supply-demand state, with prices rising from prior levels. The stock had pulled back over 15% cumulatively in the two preceding trading sessions, releasing short-term oversold rebound momentum.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜JOINN Rises 5.95% in Regular Trading, Life Sciences Sector Broadly Strengthens Amid Primate Supply Tightness Confirmed</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜JOINN Rises 5.95% in Regular Trading, Life Sciences Sector Broadly Strengthens Amid Primate Supply Tightness Confirmed\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-31 10:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 31, JOINN rose 5.95% in regular trading, trading at HKD 23.1/share, with turnover of HKD 49.71 million. The rally was driven by a broad-based rebound across the life sciences tools and services sector, with peers INSILICO up 7.42%, XTALPI up 2.79%, GENSCRIPT BIO up 2.79%, WUXI APPTEC up 2.03%, and WUXI BIO up 1.9%.</p><p>On the news front, the company recently confirmed on its investor interaction platform that domestic innovative drug financing and BD licensing transactions continue to recover, driving industry demand growth. Combined with low supply elasticity, non-human primate experimental animals are in a tight supply-demand state, with prices rising from prior levels. The stock had pulled back over 15% cumulatively in the two preceding trading sessions, releasing short-term oversold rebound momentum.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06127","symbol_name":"昭衍新药","start_time":0,"source_url":"","article_id":"1124527798","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1124527798","pubTimestamp":1785463369,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 31, JOINN rose 5.95% in regular trading, trading at HKD 23.1/share, with turnover of HKD 49.71 million. The rally was driven by a broad-based rebound across the life sciences tools and...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06127":"昭衍新药"},"translate_title":"走势警报|JOINN 常规交易上涨 5.95%，灵长类动物供应紧张得到证实，生命科学板块普遍走强","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06127":1},"content_text":"On July 31, JOINN rose 5.95% in regular trading, trading at HKD 23.1/share, with turnover of HKD 49.71 million. The rally was driven by a broad-based rebound across the life sciences tools and services sector, with peers INSILICO up 7.42%, XTALPI up 2.79%, GENSCRIPT BIO up 2.79%, WUXI APPTEC up 2.03%, and WUXI BIO up 1.9%.On the news front, the company recently confirmed on its investor interaction platform that domestic innovative drug financing and BD licensing transactions continue to recover, driving industry demand growth. Combined with low supply elasticity, non-human primate experimental animals are in a tight supply-demand state, with prices rising from prior levels. The stock had pulled back over 15% cumulatively in the two preceding trading sessions, releasing short-term oversold rebound momentum.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1124527798","isCrawlerRequest":true}